The EU’s drug watchdog on Thursday gave the green light for two antibody treatments for COVID-19, in its first approvals of the groundbreaking therapies.
The European Medicines Agency said it had approved one treatment developed by Swiss pharma giant Roche with US biotech firm Regeneron, and another by South Korea’s Celltrion.
Roche applies to market COVID antibody treatment in EU
© 2021 AFP
Citation:
EU watchdog backs two Covid antibody treatments: statement (2021, November 11)
retrieved 11 November 2021
from https://medicalxpress.com/news/2021-11-eu-watchdog-covid-antibody-treatments.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.